Bosh sahifaRGLS • NASDAQ
add
Regulus Therapeutics Inc
1,78 $
Seans yopilganidan keyin:(7,30%)-0,13
1,65 $
Yopilgan:11-apr, 17:49:14 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
1,72 $
Kunlik diapazon
1,63 $ - 1,84 $
Yillik diapazon
0,83 $ - 2,90 $
Bozor kapitalizatsiyasi
117,91 mln USD
Oʻrtacha hajm
1,72 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Haqida
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. Wikipedia
Tashkil etilgan
sen 2007
Sayt
Xodimlar soni
34
